Karo Pharma Acquires Trimb Healthcare from Avista Capital Partners
June 25, 2019
Karo Pharma AB (publ) has signed a definitive agreement to acquire Trimb Healthcare from Avista Capital Partners for SEK 3.4 billion. Trimb, a Stockholm‑based consumer healthcare company with ~90 employees and a portfolio of OTC brands, will expand Karo Pharma's geographic presence, distribution channels and product offerings in the Nordic and Northern European consumer health market.
- Buyers
- Karo Pharma AB (publ)
- Targets
- Trimb Healthcare
- Sellers
- Avista Capital Partners, Other shareholders
- Industry
- Pharmaceuticals
- Location
- Stockholm County, Sweden
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
EQT Sells Karo Healthcare to KKR
April 11, 2025
Healthcare Services
EQT VIII has agreed to sell Karo Healthcare, a pan-European consumer healthcare platform headquartered in Stockholm, Sweden, to KKR. The deal is expected to close in the coming months, subject to customary regulatory approvals.
-
KKR and Impilo Acquire Immedica Pharma
January 24, 2025
Pharmaceuticals
KKR and Nordic healthcare investor Impilo have completed a joint acquisition of Stockholm-based Immedica Pharma, with Immedica management reinvesting alongside the new owners. Immedica is a commercial-stage pharmaceutical company focused on rare and specialty diseases (notably hematology, oncology and genetic/metabolic disorders) with ~€100m revenue and more than 120 employees; CVC Credit provided debt financing and Impilo used a single-asset continuation fund supported by secondary investors.
-
Avista Healthcare Partners Acquires Trillium Health Care Products
August 7, 2024
Pharmaceuticals
Avista Healthcare Partners has completed the acquisition of Trillium Health Care Products, a Brockville, Ontario-based CDMO specializing in branded over‑the‑counter (OTC) products, from New Water Capital. Avista plans to invest in Trillium’s growth, expand its footprint and capabilities, and use the business as a consumer‑healthcare platform for potential strategic add‑on acquisitions.
-
Karo Pharma Acquires Sylphar International NV
January 13, 2023
Pharmaceuticals
Karo Pharma Aktiebolag has completed the acquisition of Belgian digital-first consumer health brand company Sylphar International NV for EUR 290 million. The deal is intended to strengthen Karo's market position and digital commerce capabilities; Sylphar CEO Robin List will join Karo's corporate management team and continue to lead Sylphar operations.
-
Avista Capital Partners Acquires WellSpring Consumer Healthcare
August 23, 2022
Consumer Products
Avista Capital Partners completed the acquisition of WellSpring Consumer Healthcare from Audax Private Equity. WellSpring, founded in 1999 and headquartered in Sarasota, Florida, is a developer and marketer of over-the-counter and personal care brands (including Bactine, Bonine, Emetrol and Glaxal Base); Avista plans to support growth through product innovation, distribution expansion and strategic acquisitions.
-
Blackhawk Growth Corp Acquires Trip Pharma Inc.
October 13, 2020
Healthcare Services
Blackhawk Growth Corp. completed the acquisition of all outstanding shares of Trip Pharma Inc., an Edmonton-based psychedelic development and wellness company led by Dr. Krista Leicht. The transaction was satisfied largely with issuance of common shares to Trip Pharma shareholders and brings Trip Pharma into Blackhawk's existing healthcare/cannabis investment portfolio as it pursues clinical research and a psychiatric research clinic focused on psilocybin-based therapies.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.